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The paper describes the inhibition of mouse acetylcholinesterase (AChE; EC 3.1.1.7) and mouse,
human, and horse butyrylcholinesterase (BChE; EC 3.1.1.8) by 5-2-(tert-butylamino)-1-hy-
droxyethyl-m-phenylene-bis(dimethylcarbamate) hydrochloride (bambuterol) and by O,O-bis-
(2-chloroethyl)-O-(3-chloro-4-methylcoumarin-7-yl) phosphate (haloxon). The haloxon inhibi-
tion rate constant (ki) for mouse BChE was 3.7 x 10
7 min–1 mol–1 dm3, which was 40-fold
higher than the rate constant for mouse AChE. Bambuterol inhibition of horse BChE (ki = 2.1 
105 min–1 mol–1 dm3) was about 25-fold slower than that of human or mouse BChE, whereas
the respective haloxon inhibition of horse BChE (ki = 1.2 x 10
7 min–1 mol–1 dm3) was about
2-3-fold slower. Sequence alignments and the computational model of the three-dimensional
structure of horse BChE suggest that residues inside the active site at positions 69, 277 and 285
are important for the differences in the inhibition of these three BChE species.
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INTRODUCTION
Acetylcholinesterase (AChE; EC 3.1.1.7) and butyryl-
cholinesterase (BChE; EC 3.1.1.8) are serine hydrolases,
that share about 55 % of amino acid sequence identity,
and have similar, yet distinct catalytic properties.1 The
different specificity for substrates, irreversible inhibitors
and reversible ligands is dictated by the difference in
amino acid residues of the active sites of AChE and
BChE.2–5 The AChE active centre is located at the bot-
tom of a deep and narrow gorge, with the surface pre-
dominantly lined with aromatic residues.6,7 Three-dimen-
sional modelling of BChE revealed an active site gorge
with fewer hydrophobic residues.8 However, the BChE
primary structures from various species also differ, and
not all residues inside the active site are conserved.9
Carbamates and organophosphates are potent inhibi-
tors of both BChE and AChE.10 We studied the inhibition
of mouse AChE and mouse, human, and horse BChE by
the carbamate 5-2-(tert-butylamino)-1-hydroxyethyl-
m-phenylene-bis(dimethylcarbamate) hydrochloride (bam-
buterol), and by the organophosphate O,O-bis(2-chloro-
ethyl)-O-(3-chloro-4-methylcoumarin-7-yl) phosphate
(haloxon) (Figure 1). The choice of the compounds was
based upon previous findings that there was a large dif-
ference between AChE and BChE in the rate of inhibi-
tion by bambuterol or haloxon.11–13 We compared the
structures of inhibitors and discussed the relationship be-
tween the size of those inhibitors and the size of AChE
and BChE active sites with inhibition rate constants. The
kinetic data in conjunction with the model of horse
BChE and the alignment of sequences of horse, human
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and mouse BChE pointed to the residues inside the ac-
tive site gorge of BChE as the probable reason for the
differences in inhibition between these species. This is
why we identified the residues, that differ in the active
sites of the three BChE species.
EXPERIMENTAL
Chemicals
Acetylthiocholine iodide (ATCh), 5,5’-dithiobis(2-nitroben-
zoic acid) (DTNB) and bovine serum albumin (BSA) were
purchased from Sigma Chemical Co., USA. Bambuterol,
5-2-(tert-butylamino)-1-hydroxyethyl-m-phenylene-bis(di-
methylcarbamate) hydrochloride, was a gift from Astra Draco
AB, Sweden. Haloxon, O,O-bis(2-chloroethyl)-O-(3-chloro-
4-methylcoumarin-7-yl) phosphate, was from Aldrich, USA.
Stock solutions (10 mmol dm–3 bambuterol in water, 10
mmol dm–3 haloxon in ethanol) were kept at 4 °C.
Enzymes
Horse serum BChE was purchased from Sigma Chemical Co.,
USA (partially purified; declared activity for butyrylthio-
choline is 22 mol per min, per 1 mg of protein, pH = 8.0,
37 °C). Recombinant mouse BChE and mouse AChE were
gifts from Professor Palmer Taylor, University of California
at San Diego, USA (purified by affinity chromatography).
Native human serum, as the source of BChE, was collected
at the Institute for Medical Research and Occupational Health,
Zagreb. Enzyme preparations were kept at –20 °C.
Enzyme Activity Measurements
Enzyme activities were determined at 25 °C using the El-
lman method and acetylthiocholine (1 mmol dm–3) as the sub-
strate.14 The reaction was started by adding the substrate to
100 mmol dm–3 phosphate buffer, pH = 7.4, containing the
enzyme, 0.33 mmol dm–3 DTNB and 0.01% BSA. All spec-
trophotometric measurements were performed on a Cary 300
spectrophotometer (Varian, Inc.).
Progressive Inhibition
In inhibition experiments enzyme samples were incubated
for up to 30 minutes with inhibitors in the absence of sub-
strate; typically, 3–5 inhibitor concentrations were used
(ranging from 2 nmol dm–3 to 2 mol dm–3 of haloxon, and
from 1 mol dm–3 to 1 mmol dm–3 of bambuterol). In all
experiments, the inhibitor concentration exceeded the enzyme
concentration. The inhibition reaction was stopped by the
addition of ATCh, and the extent of inhibition was deter-
mined by measuring the residual activity. To obtain the en-
zyme activity at zero time inhibition, the enzyme was ad-
ded to a mixture of inhibitor and ATCh.
The first-order rate constants (kobs) were calculated by
linear regression for any given inhibitor concentration us-
ing the formula:
ln (v0 / vi) = kobs t (1)
where v0 and vi stand for the enzyme activity in the absence
and in the presence of the inhibitor (I) at time t.11 The sec-
ond-order inhibition rate constant (ki) was calculated from
the linear dependency of kobs from the inhibitor concentra-
tion:
ki = kobs / I (2)
RESULTS AND DISCUSSION
In all experiments a linear relationship between the loga-
rithm of activity (percents) vs. time was obtained for any
given inhibitor concentration, and the first-order rate inhi-
bition constants, kobs, were calculated by Eq. 1 (Figure 2).
Table I displays the resulting bimolecular inhibition rate
constants ki for the inhibition by haloxon and bambute-
rol calculated by Eq. 2. The obtained constants are simi-
lar to the values published earlier.11–13,15
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Figure 1. Minimized three-dimensional structure of the substrate,
acetylthiocholine, and the inhibitors, bambuterol and haloxon.
Hydrogen atoms were subtracted for better visibility. Minimization
was performed using the MM2 molecular mechanics module in
ChemOffice Software, ChambridgeSoft Corporation, USA.
Figure 2. Inhibition of horse BChE by haloxon. Points on (A) indi-
cate the measured values. The slopes of the lines (kobs) were plot-
ted as a function of inhibitor concentrations on plot (B). The over-
all inhibition rate constant is the slope of the line on plot B.
All three BChEs were inhibited more rapidly than
AChE by any of the two inhibitors. Mouse BChE was
16000-fold more rapidly inhibited by bambuterol and
40-fold by haloxon than mouse AChE (Table I). Six ali-
phatic amino acids in the active site gorge of BChE, cor-
responding to six aromatic amino acids in AChE, make
the BChE active site gorge wider (Figure 3). Conse-
quently, bambuterol13 and haloxon have easier access to
the catalytic centre, resulting in a more efficient inhibi-
tion of BChE than of AChE. The high specificity of
bambuterol for mouse BChE, compared to AChE, de-
pends primarily on the difference in the structure of the
choline binding site where AChE has the tyrosine side
chain 337 but BChE has alanine 328.13 On the basis of
the enhanced hydrolysis of butyrylthiocholine (a specific
substrate of BChE) by AChE acyl pocket mutants5 and
of the size similarity between the haloxon chloroethoxy
group and the butyryl group, we presume a possible re-
striction of phosphorylation by haloxon, imposed by the
acyl pocket of AChE.
The inhibition of all cholinesterases by haloxon was
more potent than that by bambuterol. As shown in Fig-
ure 1, bambuterol is a bulkier molecule than haloxon,
and the difference between haloxon inhibition of mouse
AChE and mouse BChE is not very pronounced. How-
ever, the size is not the only criterion, because also rela-
tively big molecules (MW > 400) have a high affinity for
the enzyme.16 Besides the molecule size, the number of
single bonds with freedom of rotation is also important.
Molecular mechanics calculations resulted in minimized
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Figure 3. View of the residues of the
mouse AChE and human BChE ac-
tive site gorge critical for the differ-
ence in AChE and BChE specificities.
Aromatic residues Y72, Y124, W286,
F295, F297 and Y337 in mouse
AChE correspond to aliphatic N68,
Q119, A277, L286, V288 and A328
in human BChE, respectively (modi-
fied from Ref. 4).
Figure 4. Amino acid sequence alignment of horse, human and
mouse BChE.1,9,18 Letters in grey represent residues in which horse
BChE differs from human or mouse BChE. Letters in bold are
non-conserved residues inside mouse, human or horse BChE ac-
tive sites. Asterisks denote the catalytic triad S198-E325-H438.
TABLE I. Rate constants (ki) for inhibition of butyrylcholinesterase and
acetylcholinesterase by haloxon and bambuterol, determined in at
least 3 experiments(a)




Horse 12  0.8 0.21  0.01
Human 19  0.4 4.7  0.9
Mouse 37  0.6 5.7(b)
AChE
Mouse 0.87  0.05 0.00036(b)
(a) Published constants for haloxon inhibition were: for horse BChE12
ki = 15  10
6 min–1 mol–1 dm3, for human BChE12 ki = 25  10
6 min–1
mol–1 dm3, for mouse AChE15 ki = 0.25  10
6 min–1 mol–1 dm3 and for
bovine AChE11 ki = 0.21  10
6 min–1 mol–1 dm3. (b) Ref. 13.
three-dimensional structures of haloxon, bambuterol and
the substrate acetylthiocholine (Figure 1). Bambuterol,
the bulkiest molecule in our case, has nine single bonds
with freedom of rotation that can cause a significant
change in the three-dimensional structure. The smaller
haloxon has eight single bonds with freedom of rotation,
and acetylthiocholine has four such bonds. Bambuterol
with the elongated 2-(tert-butylamino)-1-hydroxyethyl
group and a relatively large phenyl-bis(dimethylcarba-
mate) group has less chance for proper orientation inside
the active site and for successful carbamoylation of
cholinesterases. Haloxon has a planar 3-chloro-4-methyl-
coumarin group, which makes it a less bulky compound
with an easier access to the catalytic centre. This could
be one of the reasons why haloxon phosphorylates both
BChE and AChE at faster rates than bambuterol.
Bambuterol significantly differentiates horse from
mouse and human BChE; it inhibits horse BChE about
25-fold slower than mouse or human BChE (Table I).
Haloxon inhibited horse BChE only 3-fold faster than
mouse BChE and only 1.5-fold faster than human BChE.
The percentage of identity of horse, mouse and human
BChE was calculated from the amino acid sequence align-
ments shown in Figure 4. Horse BChE shares 90.4 % of
the amino acid sequence with human BChE and 82.2 %
with mouse BChE. Sequence alignment of three BChE,
aligned with respect to the catalytic triad: Ser198-Glu325-
His438, pointed to 15 amino acid residues distinguishing
horse from mouse and human BChE. However, in the
three-dimensional model of horse BChE, only one of the
15 amino acid residues, threonine 69, was close to the
peripheral binding site of BChE.17 We believe that this
may influence the enzyme interactions with haloxon or
bambuterol (Figure 5). From 14 amino acid residues,
which are not conserved in any of the three BChE spe-
cies, only two amino acid residues line the active site gorge
of BChE.9 Residues at position 277, valine, alanine, and
arginine, and at position 285, leucine, proline and isoleucine,
are found in horse, human and mouse butyrylcholine-
sterases, respectively.
In conclusion, we assume that residues at positions
69, 277 and 285 are responsible for the inhibition differ-
ences of horse, human and mouse BChE. The inhibition
difference between BChE and AChE is probably dic-
tated by the choline binding site for bambuterol, and by
the acyl pocket for haloxon.
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SA@ETAK
Prou~avanje aktivnih mjesta kolinesteraza inhibicijom bambuterolom i haloksonom
Zrinka Kovarik, Anita Bosak, Goran [inko i Tatjana Latas
Acetilkolinesteraza (AChE; EC 3.1.1.7) mi{a i butirilkolinesteraze (BChE; EC 3.1.1.8) mi{a, ~ovjeka i ko-
nja inhibirane su 5-2-(tert-butilamino)-1-hidroksietil-m-fenilen-bis(dimetilkarbamat)-hidrokloridom (bambu-
terol) i O,O-bis(2-kloroetil)-O-(3-klor-4-metilkumarin-7-il)-fosfatom (halokson). Konstanta brzine inhibicije (ki)
BChE mi{a haloksonom je 3,7 107 min–1 mol–1 dm3 i 40 puta ve}a od konstante brzine inhibicije AChE mi{a.
Inhibicija BChE konja bambuterolom (ki = 2,1 10
5 min–1 mol–1 dm3) je oko 25 puta sporija nego inhibicija
BChE ~ovjeka ili mi{a. Inhibicija BChE konja haloksonom (ki = 1,2 10
7 min–1 mol–1 dm3) je 2–3 puta sporija
nego inhibicija BChE ~ovjeka ili mi{a. Razlike primarnih struktura BChE konja, ~ovjeka i mi{a, zajedno s mo-
delom trodimenzijske strukture BChE konja, upu}uju na zaklju~ak da su aminokiseline unutar aktivnih mjesta
na pozicijama 69, 277 i 285 va`ne za razlike u inhibiciji tih triju BChE.
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